Evaluation of safety and efficacy of ixazomib for multiple myeloma in real-world single institution

Teruhito Takakuwa

Presentation information

Poster Session

Sun. Oct, 14

Poster Session 3-24 Treatment for refratory/relapsed myeloma

Sun. Oct 14, 2018 1:00 PM - 1:40 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)

Chair: Hitoshi Hanamoto (Department of Hematology Kindai University Nara hospital)

[PS3-24-8] Evaluation of safety and efficacy of ixazomib for multiple myeloma in real-world single institution

Teruhito Takakuwa¹, Ippei Otomaru¹, Ayano Nishiura¹, Akiko Miura¹, Taku Araki¹, Yotaro Fujitani¹, Yasunobu Takeoka^1,2, Ryosuke Yamamura¹, Kensuke Ohta¹ (1.Hematology, Osaka Saiseikai Nakatsu Hospital, Japan, 2.Hematology, Osaka City University, Japan)

Abstract password authentication.
Password is written on a program and abstract book.